Clinical timelines
The first applicator is for the treatment of Head and Neck Cancer.
A prototype is already in use in Erasmus MC (Rotterdam, NL). The prototype is now in the transition to a commercial product. We aim for market launch mid 2025.
The second applicator is for the treatment of intact breast cancer.
Sensius products are in development and are not yet for sale.
